Avinger (STU:VG20) Institutional Ownership : 0.31% (As of Sep. 21, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Avinger Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Avinger's institutional ownership is 0.31%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Avinger's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Avinger's Float Percentage Of Total Shares Outstanding is 92.06%.

Avinger Institutional Ownership Historical Data

The historical data trend for Avinger's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avinger Institutional Ownership Chart

Avinger Historical Data

The historical data trend for Avinger can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	11.18	0.43	0.31	0.31	0.30	0.38	0.38	0.31	0.31	0.31

Avinger Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Avinger Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avinger Inc (STU:VG20) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

AVGR:USA

Address

400 Chesapeake Drive, Redwood City, CA, USA, 94063

Website

https://avinger.com

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Avinger Headlines

No Headlines